AT510867A5 - Melanogenesehemmung durch 3,5-dimethoxy-4'-hydroxystilbene und kosmetische zusammensetzungen hievon - Google Patents

Melanogenesehemmung durch 3,5-dimethoxy-4'-hydroxystilbene und kosmetische zusammensetzungen hievon Download PDF

Info

Publication number
AT510867A5
AT510867A5 ATA9089/2010A AT90892010A AT510867A5 AT 510867 A5 AT510867 A5 AT 510867A5 AT 90892010 A AT90892010 A AT 90892010A AT 510867 A5 AT510867 A5 AT 510867A5
Authority
AT
Austria
Prior art keywords
dimethoxy
hydroxystilene
melange
inhibition
cosmetic compositions
Prior art date
Application number
ATA9089/2010A
Other languages
English (en)
Other versions
AT510867A2 (de
Original Assignee
Sami Labs Ltd
Majeed Muhammed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sami Labs Ltd, Majeed Muhammed filed Critical Sami Labs Ltd
Publication of AT510867A2 publication Critical patent/AT510867A2/de
Publication of AT510867A5 publication Critical patent/AT510867A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Offenbart ist das kosmezeutische Potential von 3,5-Dimethoxy-4'-hydroxystilben im Hinblick auf dessen Melanogenese-hemmenden und fotoprotektiven Aktivitäten. Ebenfalls offenbart ist eine topische Melanogenese-hemmende Zusammensetzung, umfassend 0,01 bis 50 Gew.-% 3,5-Dimethoxy-4'-hydroxystilben.
ATA9089/2010A 2009-03-23 2010-05-21 Melanogenesehemmung durch 3,5-dimethoxy-4'-hydroxystilbene und kosmetische zusammensetzungen hievon AT510867A5 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/408,808 US20100240767A1 (en) 2009-03-23 2009-03-23 Melanogenesis inhibitiuon by 3,5-dimethoxy-4'-hydroxystilbenes and cosmeceutical compositions thereof
PCT/US2010/035766 WO2010111719A2 (en) 2009-03-23 2010-05-21 Melanogenesis inhibition by 3, 5-dimethoxy-4'-hydroxystilbenes and cosmeceutical compositions thereof

Publications (2)

Publication Number Publication Date
AT510867A2 AT510867A2 (de) 2012-07-15
AT510867A5 true AT510867A5 (de) 2012-12-15

Family

ID=42738197

Family Applications (1)

Application Number Title Priority Date Filing Date
ATA9089/2010A AT510867A5 (de) 2009-03-23 2010-05-21 Melanogenesehemmung durch 3,5-dimethoxy-4'-hydroxystilbene und kosmetische zusammensetzungen hievon

Country Status (4)

Country Link
US (1) US20100240767A1 (de)
AT (1) AT510867A5 (de)
GB (1) GB2481170A (de)
WO (1) WO2010111719A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2322159A1 (de) * 2009-10-30 2011-05-18 Green Molecular, S.L. Verwendung von Pterostilben (PTER) als Medikament zur Vorbeugung und/oder Behandlung von Hauterkrankungen, -schädigungen oder Verletzungen oder als Kosmetikmittel
US8841350B2 (en) 2011-05-11 2014-09-23 ChromaDex Inc. Method for inducing UDP-glucuronosyltransferase activity using pterostilbene
CN103393579B (zh) * 2013-08-08 2014-10-22 珀莱雅化妆品股份有限公司 一种美白修复脂质纳米粒乳液的制备方法
US10112881B2 (en) 2014-07-21 2018-10-30 Wisys Technology Foundation, Inc. Skin lightening compounds
US9980924B2 (en) * 2014-09-04 2018-05-29 The Regents Of The University Of California Topical pterostilbene compositions for use in treating UV-induced loss of barrier function in skin
WO2018034327A1 (ja) * 2016-08-17 2018-02-22 香港友池有限公司 プテロスチルベン配糖体を含む内用組成物
CN106755133B (zh) * 2017-01-20 2021-05-25 深圳大学 一种酶法制备邻苯酚类化合物的方法
CN109419634B (zh) * 2017-08-31 2023-01-31 富士胶片株式会社 水包油型乳化组合物以及皮肤外用剂
JP6807894B2 (ja) * 2017-08-31 2021-01-06 富士フイルム株式会社 水中油型乳化組成物、及び皮膚外用剤

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10175854A (ja) * 1996-10-18 1998-06-30 Dokutaazu Kosumeteikusu:Kk 津液改善用皮膚外用剤
WO1999059561A2 (en) * 1998-05-18 1999-11-25 Hensley, Kenneth, L. Resveratrol inhibition of myeloperoxidase
WO2003039557A1 (en) * 2001-11-02 2003-05-15 The Regents Of The University Of California Methods and compositions for prevention and treatment of inflammatory disease, autoimmune disease, and transplant rejection
US20030118617A1 (en) * 2001-12-21 2003-06-26 Avon Products, Inc. Resveratrol analogues
WO2003103583A2 (en) * 2002-06-10 2003-12-18 Oklahoma Medical Research Foundation A method for using tethered bis(polyhydroxyphenyls) and o-alkyl derivatives thereof in treating inflammatory conditions of the central nervous system
WO2008157787A2 (en) * 2007-06-20 2008-12-24 Kent State University Hydroxylated tolans and related compounds in the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7314634B2 (en) * 2002-02-22 2008-01-01 Steven Hernandez Use of polyphenols to treat skin conditions
US7776915B2 (en) * 2005-03-24 2010-08-17 Tracie Martyn International, Llc Topical formulations and methods of use

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10175854A (ja) * 1996-10-18 1998-06-30 Dokutaazu Kosumeteikusu:Kk 津液改善用皮膚外用剤
WO1999059561A2 (en) * 1998-05-18 1999-11-25 Hensley, Kenneth, L. Resveratrol inhibition of myeloperoxidase
WO2003039557A1 (en) * 2001-11-02 2003-05-15 The Regents Of The University Of California Methods and compositions for prevention and treatment of inflammatory disease, autoimmune disease, and transplant rejection
US20030118617A1 (en) * 2001-12-21 2003-06-26 Avon Products, Inc. Resveratrol analogues
WO2003103583A2 (en) * 2002-06-10 2003-12-18 Oklahoma Medical Research Foundation A method for using tethered bis(polyhydroxyphenyls) and o-alkyl derivatives thereof in treating inflammatory conditions of the central nervous system
WO2008157787A2 (en) * 2007-06-20 2008-12-24 Kent State University Hydroxylated tolans and related compounds in the treatment of cancer

Also Published As

Publication number Publication date
US20100240767A1 (en) 2010-09-23
GB2481170A (en) 2011-12-14
AT510867A2 (de) 2012-07-15
WO2010111719A2 (en) 2010-09-30
GB201117769D0 (en) 2011-11-30
WO2010111719A3 (en) 2010-11-18

Similar Documents

Publication Publication Date Title
AT510867A5 (de) Melanogenesehemmung durch 3,5-dimethoxy-4'-hydroxystilbene und kosmetische zusammensetzungen hievon
MX2010010508A (es) Composiciones de absorcion de sebo.
BR112013003032B8 (pt) Processo cosmético para tratar matérias queratínicas
WO2010010295A3 (fr) Composition cosmetique coloree de longue tenue
BR112015014477A2 (pt) composições para limpeza pessoal contendo aminoácido de zinco/haleto de trimetilglicina
WO2013122932A4 (en) Topical use of a skin-commensal prebiotic agent and compositions containing the same
BRPI0821235A2 (pt) Composição de moldagem termoplástica, usos de composto e de composição de moldagem termoplástica, e, fibra, folha, ou uma moldagem.
ATE547151T1 (de) Sonnenschutzformel-tagescreme
WO2009135006A3 (en) Methods for preventing oxidative damage to hair and promote hair shine
FR2940059B1 (fr) Compostion cosmetique contenant au moins deux osmolytes a effet hydratant ou anti-age
WO2009051437A3 (en) Novel use of lignan-type compounds or extract of nutmeg or aril of nutmeg comprising the same
WO2012084701A3 (en) Cosmetic composition comprising a cucurbic acid compound and a hydrophobic inulin
BR112012007685A8 (pt) Uso de derivados de benzotropolona, produto de cuidado com o corpo, agente de limpeza e tratamento doméstico, compostos, e , uso dos compostos
WO2008121315A3 (en) Compositions and methods for inhibiting melanogenesis
DE502005008631D1 (de) Dermatologischen zubereitungen
BR112014014789A2 (pt) composição
WO2011046978A3 (en) Steroidal compounds as melanogenesis modifiers and uses thereof
WO2012174096A3 (en) Personal care compositions comprising a di-amido gellant and methods of using
NZ710080A (en) Improved antimicrobial compositions
FR2929509B1 (fr) L'utilisation de glycosides d'alkyle ou de melanges de glycosides d'alkyle en tant qu'agents destines a inhiber la croissance microbienne, et compositions contenant lesdits glycosides d'alkyle.
ATE548019T1 (de) Hautaufhellende mittel, zusammensetzungen und verfahren
GB0812006D0 (en) Organic compounds
BR112015001006A2 (pt) composições farmacêuticas contendo ácido lático oligomérico
FR2973226B1 (fr) Utilisation de composes (ethoxy-hydroxyphenyl)alkylcetone ou ethoxyhydroxyalkylphenol pour traiter la peau grasse
MX2010001693A (es) Composicion pulverizable que contiene extracto de hojas de parra rojas.

Legal Events

Date Code Title Description
REJ Rejection

Effective date: 20160515